logo
Gentrified dripping: The rise of beef tallow in NZ kitchens

Gentrified dripping: The rise of beef tallow in NZ kitchens

NZ Herald08-08-2025
'I checked the expiry date before you arrived,' she said.
And?
'October. It will be fine.'
I guess she was right, because I am alive to type this tale.
The beef tallow in my bag was for Mum. Growing up, she always kept a jar of dripping in the fridge door. Carefully saved from the roasting dish, the striations of rendered tallow and residual meat juice were testament to the fat-capped shoulders and legs of butchered beasts.
We never ate this dripping on toast, because it was not the 1950s, and we had not spent the previous decade learning how to make the best of a bad world. But the fat from the last roast always crisped the spuds of the next one.
'Did you ever get to the bottom of that jar?' I asked my mum. I already knew the terrifying answer. I suspect, had olive oil not finally trickled south, she'd still be roasting spuds in that never-ending dripping.
And now that dripping has been gentrified.
Last year, purified beef fat began to infiltrate the skincare industry (aficionados swear by its moisturising properties). Meanwhile, in food stores and online, customers can buy 'premium wagyu beef tallow' and '100% organic NZ beef fat' and 'pure rendered grass fed beef tallow'.
At Woolworth's, a 450g pottle of 'pure dripping' costs $6.50. But at the newly socially acceptable 'tallow' end of the market, prices are at least double and, frequently, three or four times higher.
Yes, you read that correctly. In these Ozempic-approved times, when people pay $500 a month to NOT be fat, others are literally buying the stuff in jars.
Beef tallow, as seen in the wild.
Obviously, when Mitchells Nutrition asked if I'd like to sample their take on nature's high heat cooking oil made from 100% grass-fed and finished beef, I did not hesitate – who doesn't want to join the movement back to ancestral cooking and fry their chips with intention?
Mitchells Nutrition is a local company founded by a former professional snowboarder whose first product was powdered bone broth. The business now sells everything from beef heart capsules to functional mushrooms. Its website claims tallow is high in vitamins A, D, E and K; the label on the back of the jar describes 'a primal approach to food prep' utilising the byproducts of the bone broth (seriously, don't get me started on what the marketing department has done to soup) cooking process.
'It's very ... yellow?' says my mother.
A tablespoon of tallow the colour of creamed honey is scudding across the cast iron pan on her stove and dissolving into a pool of nostalgia. The kitchen smells vaguely of Sunday night, circa 1979. We are preparing to cook sausages, eggs and chips.
The chips are in the air fryer (because it is not actually 1979) and the sausages are ready to go.
But, first: I lower a slice of bread into the pan. It sucks up the melted fat and sizzles at the edges. Count slowly to 15. Flip the bread and count again. Lay it on a paper towel and sprinkle the surface with salt.
'Your grandma used to keep dripping in a big tin under the sink,' says my mum. 'Sometimes she made deep-fried scones for a treat ...'
I cut the single slice into quarters and offer the plate to Mum. The bread is saturated in memory. Crisp and soft at the same time.
Kim Knight is a senior journalist on the New Zealand Herald's lifestyle desk. She has a master's in gastronomy and was Canvas magazine's restaurant critic for five years.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Knox Podiatry: Caring for feet across Otago since 2013
Knox Podiatry: Caring for feet across Otago since 2013

Otago Daily Times

time4 days ago

  • Otago Daily Times

Knox Podiatry: Caring for feet across Otago since 2013

At Knox Podiatry, we combine clinical excellence with genuine care. Whatever your needs, our team of six registered and professional podiatrists are here to help you put your best foot forward. We offer a wide range of services, including nail and skin treatments, nail surgery, musculoskeletal assessments, and treatment for foot and heel pain. At our main clinic in Mosgiel, we also house a fully equipped orthotics lab and use advanced 3D scanning technology to create custom orthotics for optimal comfort and support. We also provide: Nail cutting and ingrown toenail care Corn and callus removal Diabetic foot care and annual foot checks Gait and posture analysis Plantar fasciitis treatments Footwear advice with sizes up to US 15 All new patient appointments include a thorough foot health check – Think of it like a warrant of fitness for your feet – a check-up to keep everything running smoothly. Our Mosgiel clinic is purpose-built and modern, with light bright clinic rooms, and our front desk team is always happy to help with bookings and questions. All treatments use sterilised instruments to ensure infection control protocols. We are an ACC-approved provider and registered with Southern Cross, making your treatment easier to access and claim. We stock a wide range of orthotic-friendly shoes for women and men, along with soft top bamboo and cotton socks – perfect for sensitive or diabetic feet. We also carry a selection of high-quality foot creams, as well as gel products, bunion protectors, and toe separators to support your comfort and ongoing foot care at home. New to Knox Podiatry or haven't been in over two years? – Mention this article to receive 10% discount on your first appointment. For those based in Dunedin, why not take the short drive to Mosgiel? Parking is easy and free, and it's a great excuse to explore the local shops, grab lunch, and enjoy the charm of the main street.

Ozempic and other weight-loss drugs linked to rare but serious eye conditions
Ozempic and other weight-loss drugs linked to rare but serious eye conditions

1News

time6 days ago

  • 1News

Ozempic and other weight-loss drugs linked to rare but serious eye conditions

Drugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage diabetes and obesity around the world, say researchers Flora Hui and Pete A Williams. Collectively known as GLP-1 agonists, these drugs mimic the hormone GLP-1. This limits both hunger and interest in food, helping users lose weight, and helps control blood sugar levels. But two new studies published today show that people taking these drugs may have a small increased risk of serious eye conditions and vision loss. Here's what you need to know if you're taking or considering these medications. What damage can occur? ADVERTISEMENT Non-arteritic anterior ischaemic optic neuropathy, or NAION, is a rare but devastating eye condition that occurs when blood flow to the optic nerve is suddenly reduced or blocked. It's also called an 'eye stroke'. The exact cause of NAION remains unclear and there are no current treatments available. People with diabetes are at increased risk of developing NAION. Unlike other eye conditions that develop gradually, NAION causes a sudden, painless loss of vision. Patients typically notice the condition when they wake up and discover they've lost vision in one eye. Vision tends to worsen over a couple of weeks and slowly stabilises. Recovery of vision is variable, but around 70% of people do not experience improvement in their vision. What has previous research shown? A previous study from 2024 found participants prescribed semaglutide for diabetes were four times more likely to develop NAION. For those taking it for weight loss, the risk was almost eight times higher. In June, the European Medicines Agency concluded NAION represented a 'very rare' side effect of semaglutide medications: a one in 10,000 chance. In a first for medicines regulators, the agency now requires product labels to include NAION as a documented risk. ADVERTISEMENT However the recent studies suggest the risks may be lower than we first thought. In addition to NAION, there is also evidence to suggest GLP-1 drugs can worsen diabetic eye disease, also known as diabetic retinopathy. This occurs when high blood sugar levels damage the small blood vessels in the retina, which can lead to vision loss. It may sound counter-intuitive, but rapid blood sugar reductions can also destabilise the fragile blood vessels in the retina and lead to bleeding. What do the new studies say? Two newly published studies investigated people with type 2 diabetes living in the United States over two years. The studies looked at the medical records of 159,000 to 185,000 people. One study found semaglutide or tirzepatide was associated with a more modest risk of developing NAION than previously thought. Of 159,000 people with type 2 diabetes who were taking these drugs, 35 people (0.04%) developed NAION, compared with 19 patients (0.02%) in the comparison group. The researchers also found an increased risk of developing 'other optic nerve disorders'. However, it's unclear what kind of optic nerve disorders this includes, as the medical record codes used didn't specify. ADVERTISEMENT Counter to this, the second study did not find an increased risk of NAION among those taking GLP-1 drugs. However, the researchers found a small increase in the number of people developing diabetic retinopathy in those prescribed GLP-1 drugs. But overall, participants on GLP-1 drugs experienced fewer sight-threatening complications related to their diabetic retinopathy and required less invasive eye treatments compared to the group taking other diabetes medications. Further studies are still needed to understand how GLP-1 drugs can lead to eye complications. A current, five-year clinical trial is studying the long-term effects of semaglutides and diabetic eye disease in 1,500 people, which should tell us more about the ocular risks in the future. What does this mean for people taking GLP-1 drugs? NAION is a serious condition. But we need to strike a balance between these (and other) risks and the benefits of GLP-1 medications in diabetes care, obesity treatment, reducing heart attack risks and extending lives. The key lies in informed decision-making and identifying different levels of risk. ADVERTISEMENT People with multiple NAION risk factors – such as sleep apnoea, high blood pressure and diabetes – should undergo careful consideration with their treating doctor before starting these medications. 'Crowded' optic nerve heads are also a risk factor for NAION. This is an anatomical feature where blood vessels at the optic nerve head are tightly packed together. People with crowded optic nerve heads should also undergo careful consideration before starting GLP-1 medications. Although NAION can strike without warning, regular comprehensive eye examinations with your optometrist or ophthalmologist still serve important purposes. They can detect other drug-related eye problems, including worsening diabetic retinopathy, and can identify patients with crowded optic nerve heads. It's also important to tell them if you are taking GLP-1 medications so they can keep a close watch on your eye health. Emerging research also suggests that improving your heart health might help reduce risks of developing NAION. This includes proper management of high blood pressure, diabetes and cholesterol – all conditions that compromise the small blood vessels feeding the optic nerve. Studies also show patients with heart conditions who better adhere to their medication prescriptions have lower risks of NAION than those who don't. Doctors should discuss NAION risks during prescribing decisions and work with eye care providers to monitor regularly for diabetic eye disease. Patients need clear instructions to seek immediate medical attention for sudden vision loss and the need for regular eye examinations. Aggressive treatment of sleep apnoea and other heart conditions may also help reduce NAION risks. But for now, there remains an ongoing need for more research to understand how GLP-1 medications can affect the eye. ADVERTISEMENT Flora Hui is a research fellow at the Centre for Eye Research Australia and honorary fellow at the Department of Surgery (Ophthalmology), at the University of Melbourne, Australia. Pete A Williams is a Ulla and Ingemar Dahlberg Professor in Vision Science and a research group leader, at Karolinska Institutet in Stockholm, Sweden. This article is republished from The Conversation under a Creative Commons license.

Dengue fever crisis: I caught it in Samoa and was lucky to survive
Dengue fever crisis: I caught it in Samoa and was lucky to survive

NZ Herald

time09-08-2025

  • NZ Herald

Dengue fever crisis: I caught it in Samoa and was lucky to survive

Tears streamed down my face. I was struggling to breathe without swallowing blood, but I wasn't crying just about that. I was crying because Mum was crying. It was 1995 and I was 8 years old. My Dad and I had arrived home from a holiday in Samoa the day before. We had gone there to visit my Grandma and wider aiga at Dad's village in Toamua, Faleata. It was my first trip to Samoa since I was a toddler. Two weeks of fun in the hot sun, village life and chores, yummy island food and hanging out with my cousins. Bliss. Journalist Vaimoana Mase pictured at Long Bay, Auckland. She contracted dengue fever at 8 years old on a trip to Samoa. But a day at the beach about an hour away - kuā, we called it - would result in a time my mother still cries about. The mere memory brings tears. I remember parts of that day at the beach - sprinting into the water as soon as we arrived and only getting out to eat the BBQ the parents had cooked up on the sand. There are photos of that day in an album back in Samoa - my cousins and I lining up in the shallows, striking wannabe-bodybuilder poses. Splashing water everywhere. Laughter. The best day. The rest of that trip was spent on a mattress on the sitting room floor at the house, nearly always asleep. Fatigued. Sore joints. Sore head. Sore body. Every time I sat up it felt like a chore - my head almost too heavy for me to lift. I learned how to swallow tablets - Panadol - on that trip. Other than the traditional fōfō (massages) I was given, I was not taken to the hospital. My late dad used to say they never realised how serious it was. A care package from Mum arrived with a relative that week. Inside, my childhood favourite chocolate bar: Snickers. Not even that enticed me. No appetite. My mum still remembers seeing me walking out of the airport arrivals gate in Auckland. Already a gangly child, she was shocked at how much weight I'd lost. One thing that stood out, she said, were my legs - riddled with dark dots of what she knew to be old mosquito bites. Vaimoana Mase survived dengue fever as a child in Samoa and Auckland. I could hardly stand upright, let alone walk. My eyes drooped and I wasn't my happy self, she said, describing the hug I gave her as 'weak'. The next day would reveal exactly how sick I was. The spare room is at the back of the house. I vividly remember looking up to see my mother running down the hallway to the kitchen, before racing back holding a large plastic bowl she thrust in front of me. That bowl was about to be filled almost to the rim with blood clots. Mum called an ambulance and then the Cheap Cabs' Base to get a message to my dad - a taxi driver - to come home urgently. We would pass his car on the way to the hospital. As the paramedics rushed to get me into the ambulance, Mum was still holding the big plastic bowl - she put it down on the kitchen bench as we left. My dad used to talk about what it was like walking into the home and kitchen to see that. 'Fa'alogo atu ua leai se mea i lo'u magava.' Loosely translated: his stomach dropped. No note. Just a big bowl of blood clots - and then the memory of the speeding ambulance he had passed on his way home. Vaimoana (centre) pictured in later years with cousins (L-R) Saumaleula Rachel Tapaleao and Sa Fu'a outside their family home in Toamua, Samoa. I spent three days in hospital. The doctor told Mum their daughter was 'very lucky' as the dengue fever symptoms had reached a point of severity close to the worst case scenario - death. I've only recently learned of the guilt my dad carried for many years afterwards. My mum speaks of their sleepless nights, tears and the prayers they said for their only child to live. Seeing families in our motherland of Samoa, and the wider Pacific, going through what my parents went through is so painful. Knowing the local hospitals are filled with children fighting this disease is heartbreaking. And realising families are starting to bury their children - at least one family forced to say goodbye to two sons - is devastating. Reporting about the rising death toll having survived the disease is difficult. Dengue fever can be unforgiving. I was lucky we returned home when we did. I was lucky to be able to be treated in New Zealand. I was lucky to survive. Vaimoana Mase is the Pasifika editor for the Herald's Talanoa section, sharing stories from the Pacific community. She won junior reporter of the year at the then Qantas Media Awards in 2010 and won the best opinion writing award at the 2023 Voyager Media Awards.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store